13F filing recap · Q2 2018

What did Engaged Capital buy in Q2 2018?

Reported stock-position changes between this filing and the previous one.

Stock value

$794.75M

Positions

Estimated turnover

16.7%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

New positions

ANIKAnika Therapeutics, Inc.$8.40Mreported value+262.5K shares UEICUniversal Electronics Inc.$8.32Mreported value+251.7K shares CASYCasey’s General Stores, Inc.$3.85Mreported value+36.7K shares GRPNGroupon, Inc.$3.73Mreported value+868.1K shares

Increased positions

APOGApogee Enterprises, Inc.$71.82Mreported value+492.1K shares+49.3%STKLSunopta Inc$57.60Mreported value+100.0K shares+1.5%BHEBenchmark Electronics, Inc.$39.84Mreported value+274.2K shares+25.1%BWEURBabcock & Wilcox Enterprises, Inc.$11.49Mreported value+3.47M shares

Reduced positions

CCRNCross Country Healthcare, Inc.$2.34Mreported value-284.0K shares-57.8%

Exited positions

FNSRFinisar Corporation$40.13Mprior reported value-2.54M shares-100.0%MXMagnachip Semiconductor Corp$11.34Mprior reported value-1.18M shares-100.0%IWMiShares Trust$3.19Mprior reported value-21.0K shares-100.0%